Fig. 2From: Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized studyOutcomes of haplo-HSCT in the two groups. a EBV DNAemia. b CMV DNAemia. c EBV-associated diseases. d CMV-associated diseases. e Grades II to IV acute GVHD (aGVHD). f Overall chronic GVHD (cGVHD)Back to article page